Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart

• Published in: European journal of pediatrics 2000-05, Vol.159 (5), p.322-330
• Main Authors: Rake, J P, ten Berge, A M, Visser, G, Verlind, E, Niezen-Koning, K E, Buys, C H, Smit, G P, Scheffer, H
• Format: Article
• Language: English
• Subjects: Chorionic Villi Sampling; DNA - analysis; Female; Glucose-6-Phosphatase - genetics; Glycogen Storage Disease Type I - classification; Glycogen Storage Disease Type I - diagnosis; Glycogen Storage Disease Type I - genetics; Humans; Male; Mutation; Polymorphism, Single-Stranded Conformational; Pregnancy
• ISSN: 0340-6199

We studied the glucose-6-phosphatase (G6Pase) gene of 30 unrelated glycogen storage disease type Ia (GSD Ia) patients using single strand conformational polymorphism (SSCP) prior to automated sequencing of exons revealing an aberrant SSCP pattern. In all patients we could identify mutations on both alleles of the G6Pase gene, indicating that this method is a reliable procedure. A total of 14 different mutations were identified. R83C (16/60), 158delC (12/60), Q347X (7/60), R170X (6/60) and deltaF327 (4/60) were found most frequently. Nine other mutations accounted for the other 15 mutant alleles. Two DNA-based prenatal diagnoses were performed successfully. At present, 56 mutations in the G6Pase gene have been reported in 300 unrelated GSD Ia patients and an overview of these mutations is presented. Evidence for a clear genotype-phenotype correlation could be established neither from our data nor from those in the literature. With increased knowledge about the genetic basis of GSD Ia and GSD Ib and the high detection rate of mutations, it is our opinion that the diagnoses GSD Ia and GSD Ib can usually be based on clinical and biochemical abnormalities combined with mutation analysis instead of enzyme assays in liver tissue obtained by biopsy. A newly developed flowchart for the diagnosis of GSD I is presented. Increased knowledge of the genetic basis of glycogen storage disease type I provides a DNA-based diagnosis, prenatal DNA-based diagnosis in chorionic villus samples and carrier detection.